Current Neuropharmacology
Title:Preface
Volume: 17 Issue: 1
Author(s): Thomas E. Salt
Affiliation:
Export Options
About this article
Cite this article as:
Salt E. Thomas , Preface, Current Neuropharmacology 2019; 17 (1) . https://dx.doi.org/10.2174/1570159X1701181129110951
DOI https://dx.doi.org/10.2174/1570159X1701181129110951 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
25
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation
Current Drug Discovery Technologies Targeting mTOR Pathways in Human Malignancies
Current Pharmaceutical Design The Role of Genetics in Inflammatory Bowel Disease
Current Drug Targets Mechanisms of Brain Signaling During Sepsis
Current Neuropharmacology New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration
Anti-Cancer Agents in Medicinal Chemistry Trajectories of Age-Related Cognitive Decline and Potential Associated Factors of Cognitive Function in Senior Citizens of Beijing
Current Alzheimer Research Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
Current Psychopharmacology Preface:
Current Pediatric Reviews A Review on Different Analytical Techniques for Determination of DNP Drugs and their Metabolites in Pharmaceutical Formulations
Current Pharmaceutical Analysis Aquaporin Biology and Nervous System
Current Neuropharmacology Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway
CNS & Neurological Disorders - Drug Targets Transcriptional Regulation of CYP2C19 and its Role in Altered Enzyme Activity
Current Drug Metabolism Crosstalk between Inflammation and the BBB in Stroke
Current Neuropharmacology GABA<sub>B</sub> Agonists for the Treatment of Alcohol Use Disorder
Current Pharmaceutical Design The Usefulness of Amyloid Imaging in Predicting the Clinical Outcome After Two Years in Subjects with Mild Cognitive Impairment
Current Alzheimer Research Diagnosis and Treatment of Cyclothymia: The “Primacy” of Temperament
Current Neuropharmacology Emerging Drug Therapies and Site-Specific Interventions for Autoimmune Hepatitis
Medicinal Chemistry Reviews - Online (Discontinued)